Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach

Y Tanaka, Y Luo, JJ O'Shea… - Nature Reviews …, 2022 - nature.com
The four Janus kinase (JAK) proteins and seven signal transducer and activator of
transcription (STAT) transcription factors mediate intracellular signal transduction …

Efficacy and safety of biologics and small molecule drugs for patients with moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis

JS Lasa, PA Olivera, S Danese… - The Lancet …, 2022 - thelancet.com
Background There is a growing armamentarium for the treatment of moderate-to-severe
ulcerative colitis. We aimed to compare the relative efficacy and safety of biologics and small …

Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind …

S Danese, S Vermeire, W Zhou, AL Pangan… - The lancet, 2022 - thelancet.com
Background There is a great unmet need for advanced therapies that provide rapid, robust,
and sustained disease control for patients with ulcerative colitis. We assessed the efficacy …

Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial

BG Feagan, S Danese, EV Loftus, S Vermeire… - The Lancet, 2021 - thelancet.com
Background The global prevalence of ulcerative colitis is increasing, and induction and
maintenance of remission is a crucial therapeutic goal. We assessed the efficacy and safety …

Current and future status of JAK inhibitors

DP McLornan, JE Pope, J Gotlib, CN Harrison - The lancet, 2021 - thelancet.com
An enhanced understanding of the importance of Janus kinase (JAK) and signal transducer
and activator of transcription (STAT) signalling in multiple disease states has led to an …

Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement

P Nash, A Kerschbaumer, T Dörner… - Annals of the …, 2021 - ard.bmj.com
Objectives Janus kinase inhibitors (JAKi) have been approved for use in various immune-
mediated inflammatory diseases. With five agents licensed, it was timely to summarise the …

[HTML][HTML] Tyrosine kinase 2 and Janus kinase‒signal transducer and activator of transcription signaling and inhibition in plaque psoriasis

JG Krueger, IB McInnes, A Blauvelt - Journal of the American Academy of …, 2022 - Elsevier
Plaque psoriasis is a common, chronic, systemic, immune-mediated inflammatory disease.
The Janus kinase-signal transducer and activator of transcription pathway plays a major role …

Keep calm: the intestinal barrier at the interface of peace and war

L Thoo, M Noti, P Krebs - Cell death & disease, 2019 - nature.com
Epithelial barriers have to constantly cope with both harmless and harmful stimuli. The
epithelial barrier therefore serves as a dynamic and not static wall to safeguard its proper …

Gegen Qinlian decoction relieved DSS-induced ulcerative colitis in mice by modulating Th17/Treg cell homeostasis via suppressing IL-6/JAK2/STAT3 signaling

Y Zhao, H Luan, H Jiang, Y Xu, X Wu, Y Zhang, R Li - Phytomedicine, 2021 - Elsevier
Abstract Background Gegen Qinlian decoction (GQ) is a traditional Chinese herbal
prescription that has been widely used for the treatment of bacterial dysentery and enteric …

Current and emerging strategies to inhibit type 2 inflammation in atopic dermatitis

EB Haddad, SL Cyr, K Arima, RA McDonald… - Dermatology and …, 2022 - Springer
Type 2 immunity evolved to combat helminth infections by orchestrating a combined
protective response of innate and adaptive immune cells and promotion of parasitic worm …